Check 35,000+ stocks against 26 valuation models and 37 quality factors

CanadaBis Capital Inc. (CNADF) fair value: what the stock is really worth

As of Sep 18, 2026: fair value of CanadaBis Capital Inc. $0.00, price $0.00, upside +7.7%, quality 33 out of 100. Calculated from audited financials with 26 valuation models and 37 quality factors, updated daily.

Fair value above price? Yes
Good quality? No
Add to watchlist

Healthcare · US

Thin data Sep 13, 2026

CanadaBis Capital Inc.

CNADF · US

Low PriorityFair Value upside is limited and quality is weak.

·Fair value $0.0024 · Fairly valued (+8%)

!Quality 33/100

!Expensive Growth (revenue 5y +30.7 %/yr)

!Loss-making · -8.5% net margin (TTM)

!Low debt · negative free cash flow

!Trails peers (3/10)

!Narrow moat 13/100

!Evidence only low, so the estimate is less certain

26 models, one by onewith weight and evidence Growth analysisrevenue history, year by year Quality 33/100 in detail37 factors, each one shown Compared with its peersrank on every measure, side by side

Watch CanadaBis Capital Inc. for free, get notified when fair value or trend changes. Plus fair value for all 35,000+ stocks, 14 days of Pro free, no card. Watch for free Pro now: $1 first month

What runs behind every stock

26 valuation models 8 families, DCF to NCAV 37 quality factors margins, balance sheet, cashflow, debt 6 AI factors moat, what no ratio measures 2,000+ data points verified, per stock, median

69 individual criteria per stock, every one traceable See the method →

Price vs Fair Value

White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Sep 13, 2026.

How to read this chart

37‑month range $0.0021 – $0.2246 · the $0.0022 price screens below the $0.0024 fair value. Dashed = 300-day average. As of Sep 13, 2026.

Which stocks are undervalued right now? Check free Discover now →

Company profile

CanadaBis Capital Inc. engages in the production and sale of recreational cannabis and cannabis extracts in Canada. It operates through two segments: Cultivation and Extraction. The company cultivates and distributes cannabis and cannabis products to and through, provincial liquor and cannabis boards. It is also involved in the production and wholesale distribution of cannabis extract products through the Company's manufacturing facilities to licensed distributors and cannabis producers. CanadaBis Capital Inc. was formerly known as 1926360 Alberta Ltd. and changed its name to CanadaBis Capital Inc. in April 2019. CanadaBis Capital Inc. was incorporated in 2016 and is based in Red Deer County, Canada.

Stock analysis

CanadaBis Capital Inc. (CNADF) currently trades at $0.0022, while our model-based Fair Value estimate is $0.0024, implying the stock looks roughly 7.2% fairly valued today.

Valuation

Bull case: the Economic Profit group reads highest at a median of $0.0100 per share, and 6 of the 6 models we run sit above the $0.0022 price.

Bear case: the Earnings-Based group reads lowest at $0.0100, and 0 of the 6 models stay below the price. Evidence for this calculation is low.

Quality & growth

The Quality Score stands at 33/100 (below-average quality), in the Healthcare sector.

Expensive Growth: The company is growing, but growth may require heavy reinvestment or weak cash conversion.

CanadaBis Capital Inc. reported revenue of C$16.9M in FY2025 versus C$6.9M in FY2021, a compound +25.3%/yr. Reported net income was −C$835K in FY2025.

Key figures

Market cap $304K · EPS (TTM) $−0.0100 · Net margin −4.9% · Return on equity −15.9% · Return on assets (EBIT) 3.0% · Operating margin 3.7% · Revenue (TTM) $15.1M · Revenue growth (YoY) −35.9%.

Competitive moat

Our AI-assisted moat analysis scores the competitive advantage at 28 out of 100 (low confidence).

What moves the price

For context, the median of 10 Healthcare peers we cover trades at −18% fair-value upside, at 8%, CNADF screens cheaper than that median.

Fair Value models

Bear $0.0024 Fair Value $0.0024 Bull $0.0024

Model ⓘEach model values the company its own way (discounted cash flow, earnings, assets, dividends). The fair value above is their evidence-weighted blend, not the output of a single model. Bear ⓘBear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull ⓘBull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target. Evidence ⓘEvidence = how well-backed THIS model's estimate is for this stock (0–100): how complete and reliable its input data are, and how well the model fits the company. The final Fair Value is an evidence-weighted blend, so better-evidenced models count more. Green ≥70, amber 50–69, grey below 50.

Highest evidence

ROIC Compounder $0.0100 $0.0100 $0.0100 72

EPV $0.0100 $0.0100 $0.0100 71

EV/EBITDA $0.0900 $0.1200 $0.1500 67

All 6 models by family

Earnings-Based

EPV $0.0100 $0.0100 $0.0100 71

Multiples

EV/EBIT $0.0300 $0.0400 $0.0600 64

EV/EBITDA $0.0900 $0.1200 $0.1500 67

EV/Revenue $0.0200 $0.0300 $0.0400 53

Asset-Based

NCAV (Graham) $0.0300 $0.0400 $0.0600 54

Economic Profit

ROIC Compounder $0.0100 $0.0100 $0.0100 72

Open the full fair value analysis →

Notify me when CNADF reaches fair value

Put CNADF on your watchlist. We get in touch as soon as price and fair value meet or the trend turns.

Set up alert →

Quality Score breakdown

Overall quality 33/100

Of which business quality 35 · Market factors (momentum, volatility) 13

Profitability 22

Margins and returns on capital today

Quality Growth 30

Are margins and returns improving?

Cashflow 33

Earnings quality: real cash, not paper profit

Fin. Strength 22

Balance sheet, leverage, solvency risk

Investment 39

Disciplined investing over empire-building

Low Volatility 45

Calm price path (market factor)

Momentum 0

Price trend over the last 3–12 months (market factor)

52W Momentum 0

Distance to the 52-week high (market factor)

Net Issuance 80

Share count: buybacks or dilution?

Open the full quality analysis →

Revenue & earnings trend

Growth Quality ⓘGrowth is valuable only when reinvestment earns attractive returns (Aswath Damodaran): sustainable growth depends on return on capital, reinvestment and efficiency. Basis: total company revenue over the periods shown on the cards (3Y/5Y/all years), not per share, so a merger can show up as a growth jump; per-share earnings growth is in the value-creation card. 38/100

The company is growing, but growth may require heavy reinvestment or weak cash conversion.

Revenue growth 1 year

−5.9%

Revenue growth 3 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.

+13.1%

Revenue growth 5 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.

+30.7%

’20

’21

’22

’23

’24

’25

Profit margin (trend) ⓘOperating margin then vs now, from reported annual statements. A falling margin after a boom year is the classic peak-earnings signal: the growth rate then leans on an inflated base.

−106.6% (2020) → 2.7% (2025)

What shareholders gained per year ⓘWe only publish this rate when it is defensible. Reason: fiscal 2025 is a loss year, no rate is defined from a loss

not computed

Watch CNADF, get fair value alerts →

Compare CanadaBis Capital Inc. with another stock

Price, fair value, quality and upside side by side.

First stock

Second stock

Free, no sign-up

Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Drug Manufacturers - Specialty & Generic · 609 stocks

Beats the industry median on 3/9 measures

Overall it trails its industry peers.

Valuation

Quality Score 33 · Bottom 25%

Fair Value upside −1% · Above median

Profitability

Return on assets 0% · Below median

Net margin (TTM) −9% · Bottom 25%

Operating margin (TTM) 4% · Below median

Growth and dividend

Revenue growth −36% · Bottom 25%

Balance sheet

Debt / equity 0.32× · Highest 25%

Valuation Multiplesvs Drug Manufacturers - Specialty & Generic median · lower = cheaper

P/S (TTM) 0.02× · Cheapest 25%

EV/EBITDA 4.1× · Cheapest 25%

Strength profile in five axes (Snowflake)

This stock

Sector peers

VALUE (fair-value potential)44 · sector 11

FUTURE (revenue growth)0 · sector 21

PAST (return on equity)0 · sector 25

HEALTH (low debt)84 · sector 97

DIVIDEND (yield)0 · sector 30

Context: sector, industry, market

Values & ESG

Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.

None of the checked exposures detected

Similar stocks

10 more Drug Manufacturers - Specialty & Generic stocks, each showing price versus our Fair Value estimate.

Stock	Price	Fair Value	vs Fair Value
Merck KGaA MRK	€131.45	€106.48	−19%
Takeda Pharmaceutical Company TAK	$18.64	$11.46	−39%
Jiangsu Hengrui Pharmaceuticals Co 600276	¥43.52	¥47.87	+10%
Sun Pharmaceutical Industries Limited SUNPHARMA	₹1,854	₹1,979	+7%
Galderma Group GALD	CHF 154.05	CHF 109.10	−29%
Haleon plc HLN	$9.21	$7.56	−18%
Teva Pharmaceutical Industries Limited TEVA	$38.53	$15.33	−60%
Sandoz Group SDZ	CHF 65.72	CHF 34.14	−48%
Zoetis Inc ZTS	$73.00	$104.88	+44%
Hansoh Pharmaceutical Group 3692	HK$34.34	HK$37.77	+10%

Explore undervalued stocks

More undervalued Healthcare stocks →

All undervalued stocks Technology Financial Services Healthcare Consumer Cyclical Consumer Defensive Communication Services Industrials Energy Basic Materials Real Estate Utilities Deeply Undervalued Stocks Undervalued High-Quality Stocks Undervalued Blue-Chip Stocks Undervalued Small-Cap Stocks Undervalued Dividend Stocks

Try a ready-made strategy

Pick a strategy and jump into the live analysis with that exact screen applied.

🥇 Backtested Best 🏆 Big Names ⭐ Top Rated 💎 Quality on Sale 🚀 Profitable Growth 🧊 Quality Compounders 💵 Dividend Stars 📈 Strong Momentum 📉 Fallen Angels ⚖️ Deeply Undervalued 🔍 Small-Cap Gems 🏰 Moat at a Fair Price 💼 Insider Buying 🎩 Buffett-Style Quality 📚 Peter Lynch GARP 🧮 Greenblatt Magic Formula 🛡️ Graham Defensive

Discover tools

Stock screenerFilter by region, size and sector Compare toolTwo stocks side by side Extrinsic Value Calculator…Calculator with industry benchmark Peter Lynch Fair Value Formula &…Calculator with industry benchmark

Run the numbers yourself: free valuation calculators

DCF Calculator Graham Number Peter Lynch Formula DDM Calculator Fama-French Model Intrinsic Value

For bloggers & editors: embed code + live data

For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.

CanadaBis Capital Inc. · Fair Value
$0.0024 +7%Fair Value
Calculator →

<a href="https://www.fairvalue-calculator.com/stock/CNADF" target="_blank" rel="nofollow noopener" style="display:inline-flex;align-items:center;gap:12px;box-sizing:border-box;font-family:system-ui,-apple-system,Segoe UI,Roboto,sans-serif;text-decoration:none;background:#0f1814;color:#eaf2ed;border:1px solid #2a3a30;border-radius:12px;padding:12px 16px;max-width:360px"><span style="line-height:1.35"><span style="font-size:12px;color:#9fb0a8">CanadaBis Capital Inc. · Fair Value</span><br><b style="font-size:20px">$0.0024</b> <span style="color:var(--fvc-g-mitte);font-weight:700;font-size:14px">+7%</span></span><span style="font-size:11px;color:var(--fvc-g-mitte);font-weight:700;margin-left:auto;text-align:right;line-height:1.3">Fair&nbsp;Value<br>Calculator&nbsp;→</span></a>

Cite: Fair Value Calculator (2026). "CanadaBis Capital Inc. Fair Value". https://www.fairvalue-calculator.com/stock/CNADF

Frequently asked questions

Is CanadaBis Capital Inc. (CNADF) overvalued or undervalued?

As of Sep 13, 2026, our model estimates a fair value of $0.0024 versus a price of $0.0022, about +8% upside (fairly valued).

What is the fair value of CNADF?

Our model-based fair value for CanadaBis Capital Inc. is $0.0024 (as of Sep 13, 2026), built from audited fundamentals. The current price: $0.0022.

What is the quality score of CNADF?

CanadaBis Capital Inc. has a Quality Score of 33/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.

What is the price target for CanadaBis Capital Inc. (CNADF)?

Our model-based price target is the fair value of $0.0024 (as of Sep 13, 2026) from 6 valuation models. It is a calculation from audited fundamentals, not an analyst target.

What is the CanadaBis Capital Inc. stock forecast for 2026?

Our models put fair value at $0.0024, about +8% upside versus a price of $0.0022 (fairly valued). The calculation is refreshed regularly with new filings.

What is the revenue of CanadaBis Capital Inc. (CNADF)?

CanadaBis Capital Inc. reported trailing-twelve-month revenue of about $15.1M (latest available figure, as of Sep 13, 2026).

What is the intrinsic value of CanadaBis Capital Inc. (CNADF)?

Intrinsic value and fair value mean the same thing: what the business is worth on its numbers, independent of the share price. For CanadaBis Capital Inc. it is $0.0024 per share (as of Sep 13, 2026), against a price of $0.0022. It is the blended result of 6 valuation models (cash flow, earnings, asset, dividend).

Is CanadaBis Capital Inc. stock overvalued or undervalued in 2026?

As of Sep 13, 2026, CNADF trades below its calculated fair value: price $0.0022, fair value $0.0024, a gap of about +8% (fairly valued). The calculation is refreshed with each new quarterly report, so the verdict can change during the year.

Is fair value the same as the market price of CNADF?

No. The price is what the market pays today ($0.0022); the fair value is what the company's own numbers justify ($0.0024). For CanadaBis Capital Inc. the two are $0.0002 per share apart. That gap is exactly why we show both numbers side by side.

How much is CanadaBis Capital Inc. worth?

The market values CanadaBis Capital Inc. at about $304K (market capitalisation, as of Sep 13, 2026). Per share that is $0.0022; our models calculate a fair value of $0.0024 per share.

How solid is the balance sheet of CanadaBis Capital Inc. (CNADF)?

Balance-sheet figures for CanadaBis Capital Inc. (as of Sep 13, 2026): return on equity −15.9%, debt of 0.32 per unit of equity. They feed the Quality Score of 33/100, which measures business quality independently of the share price.

Which stocks are comparable to CanadaBis Capital Inc.?

From the same area (Healthcare) we also value Merck KGaA, Takeda Pharmaceutical Company, Jiangsu Hengrui Pharmaceuticals Co, Sun Pharmaceutical Industries Limited, among others. Each of them has its own fair-value calculation on this site using the same models, so the comparison is like for like.

Is CanadaBis Capital Inc. stock attractive at the current price?

The data as of Sep 13, 2026: price $0.0022, calculated fair value $0.0024 (+8%), Quality Score 33/100, from 6 models. Whether that fits your horizon and risk tolerance is your call. We provide the calculation, not investment advice.

How is the fair value of CNADF calculated?

We run CanadaBis Capital Inc. through 6 models from four families: discounted cash flow, earnings models, asset and balance-sheet models, and dividend models. Every model gets the same audited fundamentals; the result is the weighted average of $0.0024, with the spread shown as a cautious and an optimistic scenario.

Is it still worth investing in stocks now?

The global stock market currently sits 16.2 % above its aggregate fair value. CanadaBis Capital Inc. currently trades 8 % below its own fair value, and the market average says nothing about that. An expensive market is no reason to stay out and no reason to buy everything at once: keep a broad savings plan running, buy single stocks only with money you can do without, and hold part of your money liquid while the market is high. The full picture including sectors is on is it worth investing now.

What is the share price of CanadaBis Capital Inc. (CNADF)?

The closing price on Sep 18, 2026 was $0.0022. Our model-based fair value is $0.0024, about +8% upside (fairly valued). We carry closing prices from our data provider, not a live tick.

What should I pay attention to with CanadaBis Capital Inc. right now?

The price is below even our cautious bear case ($0.0024). The market is more pessimistic than our downside scenario. The price sits close to our fair value, market and models broadly agree here, little valuation tension. Evidence is limited here (fewer models, shorter history), so the fair value is a rougher estimate than usual.

Key figures of CanadaBis Capital Inc.

How large is the market capitalisation of CanadaBis Capital Inc. (CNADF)?

The market capitalisation of CanadaBis Capital Inc. is $304K. The stock-market value of the whole company: share price times number of shares. It is what the market asks for the entire business today.

What are the earnings per share of CanadaBis Capital Inc. (CNADF)?

Earnings per share at CanadaBis Capital Inc. are $−0.0100. Earnings per share over the last twelve months: total profit spread across every single share.

What is the net margin of CanadaBis Capital Inc. (CNADF)?

The net margin of CanadaBis Capital Inc. is −4.9% (fiscal year 2025). How much of every unit of revenue ends up as profit. 10% means 10 cents of profit per dollar of sales.

What is the return on equity of CanadaBis Capital Inc. (CNADF)?

The return on equity (ROE) of CanadaBis Capital Inc. is −15.9% (last twelve months). Profit relative to shareholders' equity, how efficiently the company works with its owners' money.

What is the EBIT return on assets of CanadaBis Capital Inc. (CNADF)?

On an EBIT basis the return on assets of CanadaBis Capital Inc. is 3.0% (avg 5y). Operating profit (EBIT) relative to everything the company owns, as a multi-year average. It describes the business model rather than one good or bad year.

What is the operating margin of CanadaBis Capital Inc. (CNADF)?

The operating margin of CanadaBis Capital Inc. is 3.7% (last twelve months). Profit from the core business (before interest and taxes) relative to revenue.

How fast is revenue growing at CanadaBis Capital Inc. (CNADF)?

Revenue at CanadaBis Capital Inc. is growing −35.9% versus a year earlier (3y avg +13.1%). How much revenue grew versus a year earlier (YoY). The 3-year average next to it puts the single year in context.

How fast are earnings growing at CanadaBis Capital Inc. (CNADF)?

Earnings per share at CanadaBis Capital Inc. are growing −11.8% versus a year earlier. How much earnings per share grew versus a year earlier.

How much free cash flow does CanadaBis Capital Inc. (CNADF) generate?

The free cash flow of CanadaBis Capital Inc. is −$3.4M (fiscal year 2025). The cash truly left after running and investing in the business, this is what pays dividends and buybacks.

How much net debt does CanadaBis Capital Inc. (CNADF) carry?

The net debt of CanadaBis Capital Inc. is $6.3M (fiscal year 2025). Debt minus cash on hand. The note shows how many years of free cash flow could in theory pay it off.

Free · no account needed

Watch CanadaBis Capital Inc. in the live analysis

One click puts CanadaBis Capital Inc. on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 35,000+ stock screener. You can also try 14 days of Pro there, no card.

Watch for free →

Zero risk: nothing is ever charged. Your watchlist is yours, with or without an account.